Peter Greenleaf, Aurinia CEO
May 11, 2023 07:19 AM EDTUpdated 11:27 AM
People

Au­rinia’s board gets push­back from an­oth­er share­hold­er as Iljin fol­lows MKT Cap­i­tal’s lead

Kyle LaHucik

Senior Reporter

It’s the not-so-lucky sev­en for Au­rinia Phar­ma­ceu­ti­cals.

Ko­re­an in­vestor Iljin SNT is with­hold­ing sup­port for sev­en of the Cana­di­an biotech’s eight …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Phar­ma's wins and loss­es in Trump's sprawl­ing ex­ec­u­tive or­der on drug prices

US drugs re­ly heav­i­ly on in­gre­di­ents made over­seas, new re­port shows

Nether­lands pours $1.5B in­to biotech in pur­suit of glob­al lead­er­ship am­bi­tions

Eli Lil­ly re­ports first Phase 3 da­ta for oral GLP-1, post­ing a win in di­a­betes

Biotech seed rounds sink to low­est lev­el in years as in­dus­try slump drags on

sponsored

New York-based part­ner­ship sets the stan­dard for ex­pand­ing clin­i­cal tri­al ac­cess for un­der­served and di­verse ...

A service from the Financial Times